Capillary Technologies India Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹257Cr
- +42.8% YoY
- +34.6% QoQ
- Net profit
- −₹10Cr
- Q1 FY26: ₹1 Cr
- Margin
- 16%
- +6 pp YoY
- 0 pp QoQ
Guidance rank: #9 of 39 in IT - Software
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
2 of 3 strong
The short version
Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA. Capillary Technologies expects to exceed its revenue guidance of INR1,065 crores and INR172 crores EBITDA.
From Capillary Tech.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA.
- New Annual Contract Value (ACV) grew about 75% YoY, indicating strong momentum in new sales across US, Europe, and Asia.
- Organic growth guidance for FY27 is around 17%-23%, with inorganic growth supplementing this.
- SessionM acquisition adds to revenue with server cost efficiencies improving margins; migration expected over 2-3 years.
- Net Retention Rate (NRR) expansion and upselling new AI products contribute to higher revenues and margins.
- Company targets combined 15%-20% organic growth with ongoing inorganic acquisitions as a sales motion.
2 more points from Capillary Tech.'s call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Capillary Tech. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in IT - Software
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Capillary Tech. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The ACV (Annual Contract Value) reported was INR 92 crores, up from INR 53 crores previously, representing about 80% growth on a trailing 12-month basis.
- Average deal cycles are approximately 9 months, so quarter-to-quarter comparisons are less meaningful.
- There is strong momentum in new sales across the US, Europe, and Asia.
- Expecting at least 30%-40% more new ACV than last year, though unlikely to hit 75% growth for the full year.
2 more points from Capillary Tech.'s call on order book
Create a free account to keep reading this call
Capillary Tech. — Quarterly revenue & net profit
Capillary Tech. Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 257 | 180 | +42.8% | 191 | +34.6% |
| Operating profit (EBITDA) | 40 | 18 | +122.2% | 31 | +29% |
| Operating margin | 16% | 10% | +6 pp | 16% | 0 pp |
| Profit before tax | -9 | 1 | -1000% | 42 | -121.4% |
| Net profit (PAT) | -10 | 1 | -1100% | 43 | -123.3% |
| EPS (₹) | -1.20 | 0.10 | -1300% | 5.46 | -122% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹271 Cr, net profit ₹22 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Capillary Technologies India's management said in earlier quarters
Others in IT - Software this season
- Delaplex (Q1 FY27)
H2 FY26 total income (quarterly equivalent): ₹340.4 Mn vs ₹328.4 Mn in H2 FY25, a 3.66% YoY increase. Key investor presentation takeaways from Delaplex Ltd's Q1
- Xelpmoc Design (Q1 FY27)
Q1 FY27 Revenue from Operations: Rs 9.6 million, up 22.5% YoY from Rs 7.8 million in Q1 FY26 (Page 27). Key investor presentation takeaways from Xelpmoc Design'
- Cybertech Systems & Software (Q1 FY27)
Total Revenue: ₹766.3 million, up 17.5% YoY (Page 3, 15, 19) . Key investor presentation takeaways from Cybertech Systems & Software Ltd's Q1 FY27 investor pres
- Workmates Core2 (Q1 FY27)
FY26 total revenue: ₹143 Cr (Page 10) . Key concall takeaways from Workmates Core2cloud Solution Ltd's Q1 FY27 earnings call — and how it ranks against sector…
Potential multibaggers · Q2 FY27
Potential multibaggers in IT - Software
on management's own guidance
- Strong growth2
- Strong growth1
- Fractal AnalyticsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Capillary Tech. and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Capillary Tech. Q1 FY27 results?
Capillary Technologies expects to exceed their revenue guidance of INR1,065 crores and INR172 crores EBITDA. Capillary Technologies expects to exceed its revenue guidance of INR1,065 crores and INR172 crores EBITDA.
What is Capillary Tech. share price analysis?
Capillary Tech. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 78.0 with a market cap of ₹3,998 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Capillary Tech. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
